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Hypothetical applications of functional human genomic maps
in medical genetics can include a wide range of diagnostic tech-
niques and therapeutic approaches. Comparative analysis of
proteome maps of normal cells and those of malignant cells
can, for instance, depict functional deviations of the genome
in cancer cells and detect oncogenic proteins synthesized and
expressed by the malignant cell and responsible for pathogen-
esis and development of the malignant phenotype.Oncoprotein
maps constructed from this information would, certainly, have
beneﬁcial impact on research studies aiming at better, and
proper, understanding of malignant transformation through
targeting pivotal oncoproteins that initiate and promote the
malignant phenotype of cancer cells. They would, also, have
similar impact on research studies aiming at designing and tai-
loring speciﬁc therapeutic trials for challenging carcinogenesis
through e.g. engineering of monoclonal antibodies against rel-
evant oncoproteins inside intracellular compartments as well
as on cell membranes and within intercellular spaces. Interrup-
tion of signaling pathways involved in the mediation of many
selective advantageous functions of malignant cells, e.g. en-
hanced glycolysis, metastasis and neovascularization, which
depend on the synthesis of speciﬁc oncoproteins could, proba-
bly, represent a promising approach in the treatment of cancer* Tel.: +20 1225874345.
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http://dx.doi.org/10.1016/j.ejmhg.2013.12.005via disassembly of metabolic and regulatory networks actively
participating in malignant transformation and development of
the malignant phenotype.
On the molecular level, comparative analysis of transcrip-
tome maps of messenger RNA and those of different micro
RNA species in normal and in diseased subjects could offer
remarkable help in the diagnosis of genetic diseases character-
ized by substantial genomic activities. Malignant cells express
large numbers of actively transcribed genes, and detailed can-
cer-speciﬁc transcriptome maps could be constructed for path-
ologically distinct types of malignancies, thus allowing for
better understanding of the aberrant phenomena of differential
suppression of certain genes and of mass overexpression of
speciﬁc gene families, e.g. proto-oncogenes, in malignant cells.
They can also offer more information on the genic and inter-
genic pathogenetic and pathological mechanisms underlying
the development of speciﬁc types of cancer. Cancer-speciﬁc
transcriptome maps and oncoprotein maps constructed for
pathologically distinct types of malignancies might offer rapid
and accurate diagnostic tools of these malignancies when com-
pared with corresponding maps of normal cells. Delineation of
the whole spectrum of proto-oncogenes and of oncogenes in
the human genome and construction of informative maps
detailing relevant databases of this spectrum remains, and rep-
resents, a prospective ultimate goal crucial for understanding
and designing radical therapies for cancer.
6. Developmental genomic, proteomic and transcriptomic maps
During embryonic and fetal development, and to much lesser
extent during early post-natal life, organ and tissue-speciﬁc dif-
ferential suppression of large numbers of certain sets of genes,in Shams University.
Table 2 Types of genetic maps.
A. The family pedigree
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similar numbers of other sets of genes, is indispensable for
normal regulation, synchronization and progression of consec-
utive processes of differentiation, specialization, growth and
development. Comparative analysis of genome, transcriptome
and proteome functional maps during each of these stages of
embryonic and fetal life could disclose the intimate correlations
between synchronized activities of these three components, and
reveal many obscure aspects of temporal regulation of these
activities during this critical period of life. This information
might prove helpful in understanding genomic regulation of
development stages and revealing genetic disturbances that pre-
dispose to the pathogenetic mechanisms and the pathophysio-
logical alterations that mediate and underlie the development
of congenital malformations. Comprehensive understanding
of these aspects of genetic regulation of development represents
a pre-requisite step indispensable for hypothesizing and design-
ing effective prophylactic measures and early therapeutic inter-
vention approaches against teratogenesis.
Additionally, analysis of formal databases of structural and
functional genomic and proteomic maps of fetal development
can add, signiﬁcantly, to our current vague and scanty knowl-
edge of many, still, unknown aspects of regulatory genetic
mechanisms, particularly those of genetic and genomic
imprinting and temporal synchronization of mass suppression
and activation of large, sometimes, huge numbers of genes that
characterize development and differentiation. The role played
by increased transposon activity in causing, seemingly, sponta-
neous mutagenic events that predispose to developmental mal-
formations during fetal development deserves serious attention
if effective prophylactic and therapeutic anti-teratogenic mea-
sures are to be hypothesized and designed. Also, the effective
opposition of this teratogenic mechanism by the silencing ac-
tion exerted by piwiRNA on transposon regulatory sequences,
represents an important regulatory mechanism responsible for
maintaining genomic integrity and genomic stability during
this critical period of life. Comparison of malformation-spe-
ciﬁc transposon maps with their normal counterparts would
offer invaluable information which can be used to construct
anomaly-speciﬁc databases correlated with these particular
transposon maps that depict speciﬁc overexpressed transpo-
sons in speciﬁc types of congenital malformations. These data
could have both predictive value in delineating malformation-
causing transposons, as well as potential therapeutic and/or
prophylactic application by choosing and designing proper
and speciﬁc piwiRNA silencing molecules against these partic-
ular anomaly-causing transposons.B. Physical maps
1. Genomic maps
2. Sequence maps
3. Gene maps
4. Chromosome maps
5. Transposon maps
6. Pseudogene maps
7. Pyknon maps
8. Linkage maps
C. Induced/experimental maps
1. Hybridization maps
2. Radiation hybrid maps
3. Restriction fragment polymorphism maps
4. Probe-speciﬁc maps
5. Disease-association maps7. Limitations of formal genetic analysis
Computational analysis of bioinformatics databases repre-
sented by different types of formal genetic maps, whether for
comparative or predictive purposes, represents a real chal-
lenge. Not only because of lack of many pieces of information
necessary to complete these maps, but also due to paucity of
our knowledge as regards basic essential genetic mechanisms
that regulate the structural integrity and functional specializa-
tion of the genome as a whole. For instance, the nature of the
real regulatory systems that master the highly conserved spe-
cies-speciﬁc genetic constitutions of all creatures, including
the human genome, is extremely vague, without any clues tothe possibility of disclosing the design or the components of
the genetic material responsible for it, even in the near future.
Similarly, the signiﬁcance of many puzzling and enigmatic phe-
nomena regarding the known detailed structure and actual
functions of the genetic material continues to be a matter of
debate in spite of the many theories and hypotheses trying to
explain them. Examples of such phenomena include genetic
imprinting, transposon activity, apoptosis, metabolic adapta-
tions and many others. However, the nature of the mecha-
nisms through which biomolecules, notably nucleic acids and
proteins, can conceive, interpret and execute pre-programed
biological processes that are embodied within their structural
conﬁguration remain on the top of these unsolved phenomena.
8. Formal genetic maps
Formal genetic maps comprise three main categories that are
widely used in clinical, diagnostic and experimental genetics.
They include: the family pedigree, physical maps and induced
or experimentally constructed maps (Table 2).
8.1. The family pedigree
The family pedigree is a simple graphic interface ﬁgure in-
tended for presentation of information and data of patients
with genetic diseases or families with a history of genetic dis-
eases. It summarizes personal and family data of examined
or counseled cases and their concerned family members, thus
allowing rapid collection and interpretation of presented data,
inference of possible patterns of inheritance, deduction of
assumptions regarding probable etiologies of recorded ﬁndings
and identiﬁcation of family members in need of further diag-
nostic/prognostic investigations or conﬁrmatory tests to reveal
their carrier status, so that proper counseling advice could be
offered to them. Additionally, properly constructed pedigree
is mandatory for formulation of proper counseling approaches
to concerned patients and their related family members. Fam-
ily pedigree construction utilizes arbitrary symbols agreed
upon by most geneticists and used to depict and represent spe-
ciﬁc data and information of the pedigree. Additional impor-
tant and informative data of members represented in the
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analyzed with the rest of the data of the pedigree (Figs. 1 and
2) [1].
8.2. Patterns of inheritance
Genetic diseases manifest distinctive wide variations as regards
their ways of occurrence and recurrence, as well as their ways
of inheritance, or transmission, from parents to offspring. The
speciﬁc patterns of inheritance of genetic diseases describe the
characteristic features which outline, control and regulate the
transmission of genetic traits or diseases from normal, carrier
or affected parents to their offspring. These features vary
widely according to the actions and interactions of many ge-
netic factors in addition to many other modifying genetic
and/or environmental conditions.
The pattern(s) of inheritance of a speciﬁc genetic disease de-
pends on many factors including whether the disease is caused
by single mutant gene, by more than one gene or by a multifac-
torial genetic-environmental interaction, the gene locus, the
status of the transmitting parent(s), the nature of the gene
product(s), the causative pathogenetic mechanism(s) underly-
ing the development of the disease, and whether this transmis-
sion happens in a classic traditional manner or within the
context of an abnormal genetic framework.
The distinction between genetic diseases due to single mu-
tant genes, referred to as single gene disorders, and other types
of genetic diseases is of prime importance because it makes a
clear delineation between genetic disorders that follow speciﬁc
rules of inheritance referred to as classic/traditional or Mende-
lian patterns of inheritance, and other genetic diseases caused
by different genetic mechanisms that do not follow these clas-
sic rules. They, rather, follow other rules referred to as non-
Mendelian/non-classic or non-traditional patterns of inheri-
tance. Accordingly, two main patterns of inheritance of genetic
disorders could be identiﬁed: Mendelian/classic/traditional pat-
tern of inheritance of single gene disorders and non-Mendelian/
non-classic/non-traditional pattern of inheritance of other types
of genetic disorders (Table 3) [2].
The locus of the mutant gene deﬁnes the nature of the ge-
netic disorder in two different ways. First, it deﬁnes three
broad groups of genetic diseases: nuclear gene diseases due toFig. 1 Different symbols used in constructiomutant genes located on the chromosomes in the nucleus,
mitochondrial disorders due to mutant genes of the mtDNA
and combined nuclear-mitochondrial genetic diseases due to
affection of both nuclear and mitochondrial genes, e.g. oxida-
tive phosphorylation disorders. Alternatively, it can delineate
three different categories of single gene disorders each having
its own speciﬁc pattern(s) of inheritance: autosomal diseases
caused by genes located on the autosomes, sex-linked diseases
caused by genes located on the sex chromosomes and mito-
chondrial disorders caused by mutations of mitochondrial
genes. Sex-linked diseases are further classiﬁed into X-linked
diseases caused by mutant genes on the X-chromosome and
Y-linked diseases caused by mutant genes lying on the Y-
chromosome.
An individual having both normal genes, or alleles, trans-
mitted from both parents is termed a normal or a homozygote
normal. An individual having both abnormal, defective or mu-
tant genes transmitted from both parents is termed a homozy-
gote diseased or affected individual. An individual having a
normal gene transmitted from one parent and an abnormal,
defective or mutant gene transmitted from the other parent
is termed a carrier or a heterozygote. Males with single X-chro-
mosome are hemizygotes for genes located on the X-chromo-
some since they have only one copy of these genes.
The status of the transmitting parent, or both parents,
determines many different aspects of the pattern(s) of inheri-
tance of the inherited disease. For single gene disorders, one
aspect deﬁnes the transmission of the gene in a dominant or
a recessive way, for both autosomal and sex-linked genes.
So, we have ﬁve main different patterns of inheritance based
on the way of transmission of the single mutant gene relative
to the status of the transmitting parent(s). These patterns
are: autosomal dominant (AD), autosomal recessive (AR),
X-linked dominant, X-linked recessive and Y-linked patterns
[3].
8.2.1. Autosomal dominant inheritance
For human traits and diseases, dominance refers to the ability
of the gene to confer a speciﬁc phenotype on the individual
harboring it when present in a single copy or allele. An auto-
somal dominant (AD) genetic disease entails the presence of
one mutated allele of the disease-causing gene on one of then and description of the family pedigree.
Fig. 2 The family pedigree.
Table 3 Patterns of inheritance of genetic traits/diseases.
Mendelian/classic/traditional patterns Non-Mendelian/non-classic/non-traditional patterns
1. Autosomal dominant diseases 1. Genetic imprinting: genic–genomic
2. Autosomal recessive diseases 2. Uniparental disomy (UPD): heterodisomy–isodisomy
3. X-linked dominant diseases 3. Trinucleotide, or triplet repeat, expansion
4. X-linked recessive diseases 4. Mitochondrial inheritance
5. Y-linked diseases 5. Microdeletion/microduplication syndromes
6. Gonadal mosaicism
7. Multifactorial disorders
8. Nuclear/mitochondrial disorders
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mosome, and the pathogenesis of a speciﬁc disease phenotype
due to defective and/or deﬁcient production of the structural
protein encoded by the mutated gene.
Since autosomal dominant genes exist on the autosomes,
they can be transmitted to either male or female offspring,
and as only half the germ cells of the parent having the disease
gene are affected, with the other half having the other normal
allele, there is 50% statistical chance in each conception of
having an affected offspring and 50% chance of having a nor-
mal free offspring.
As autosomal dominant diseases are caused by single mu-
tant genes, there are no carriers of these diseases, rather there
are affected diseased heterozygotes and, in some rare excep-
tional conditions, affected diseased homozygotes if both alleles
of the gene are mutated.
Penetrance and expressivity
Penetrance is the probability that a dominant disease will
appear in an individual when a disease-allele is present.
For example, if all the individuals who have the disease-
causing allele for a dominant disorder have the disease,
the allele is said to have 100% penetrance. If only a quarter
of individuals carrying the disease-causing allele show signs/
symptoms of the disease, the penetrance is 25%. Expressiv-
ity, on the other hand, refers to the range of signs/symptoms
that are possible for a given disease. For example, an inher-
ited disease like the Marfan syndrome can have either severeor mild phenotype and can have either a partial or full
range of expression with affection of the skeletal, ocular
and cardiovascular systems.
8.2.2. Autosomal recessive inheritance
An autosomal recessive (AR) genetic disease entails the pres-
ence of two mutant alleles of the disease-causing gene on both
autosomes. The pathogenesis of a speciﬁc recessive disease
phenotype results from absence, in varying degrees ranging
from total absence to mild deﬁciency, of the gene product or
synthesis of defective gene product. Contrary to autosomal
dominant diseases, carriers of autosomal recessive genes are
typically normal. They might show some disease manifesta-
tions only under exceptional conditions, e.g. stressful physio-
logical circumstances or abnormal metabolic derangements.
Recessive genes need to exist in two copies, or alleles, in order
that a speciﬁc recessive disease or trait phenotype can show up.
Homozygosity, or similarity, of both alleles (disease causing
genes) on both autosomes which results in total absence or se-
vere deﬁciency of the gene product, is a pre-requisite for path-
ogenesis and development of the disease phenotype.
This difference between dominant and recessive diseases
can be attributed, in part, to the different underlying pathoge-
netic mechanisms and might be explained in view of the spe-
ciﬁc pathological characteristics of each type. Dominant
diseases result, mostly, due to deﬁcient and/or defective pro-
duction of structural proteins produced by mutant genes.
These structural proteins are vital integral constituents of
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ton, cell organelles, spindle apparatus, chromatin material and
mitochondrial components. Structural proteins deﬁne all ana-
tomical aspects and regulate dynamics of cellular activities like
cell division, cell movement and cell migration, signaling path-
ways, intercellular contact and many others. In AD diseases,
50% reduction of the amount, or functions, of these structural
proteins happens which is a drastic burden that cannot be tol-
erated by the cell, hence the expression of the disease pheno-
type in heterozygotes of AD genes. Autosomal recessive
diseases, on the other hand, comprise genetic diseases resulting
mostly from deﬁcient and/or defective production of catalytic
proteins that act as enzymes rather than as structural proteins.
Enzyme dynamics allow for mediation of prolonged and recur-
ring metabolic reactions by small limited amounts of the en-
zyme, sometimes as low as 5% of the amount needed under
normal conditions. Hence, for an AR disorder to be expressed
in an affected patient, mutation of both genes is required thus
necessitating a carrier or heterozygous status of both parents,
except under exceptional abnormal conditions like parental
disomy, for instance.8.2.3. X-linked inheritance
X-linked inheritance refers to patterns of inheritance of traits
and diseases caused by genes located on the X-chromosome.
Though a normal female has two X-chromosomes in her so-
matic cells, only one of these two is active and the other, for
most of its genes, is inactive. This phenomenon of inactivation
or suppression of one of the two X-chromosomes in any nor-
mal female somatic cell is termed Lyonization of the X-chro-
mosome. Lyonization, or inactivation of all X-chromosomes
but one in somatic cells, happens very early during the ﬁrst
two weeks of embryonic development. Most important is its
apparent random occurrence, i.e. it can affect either the pater-
nally or the maternally inherited X-chromosome. Also, once it
happens, the inactivation of a particular X-chromosome in a
cell continues to affect the same inherited chromosome in all
daughter descendent cells of the original cell.
The implications of the process of Lyonization include the
following aspects:
1. Any normal female has only one active X-chromosome
in each of her somatic cells.
2. Any somatic cell has only one active X-chromosome
regardless of the number of X-chromosomes in the cell,
i.e. all X-chromosomes in excess of one get Lyonized,
suppressed or inactivated.
3. Any normal female has a mosaic genotype for her X-
linked genes since, on the average, half of her cells has
one active chromosome inherited from one parent and
the other half has one inactive X-chromosome inherited
from the other parent.
4. If a female inherits a mutant X-linked gene from one of
her parents, on the average, half of her cells will have
the X-chromosome carrying the mutant gene and the
other half will have the normal chromosome carrying
the normal gene. Accordingly, most females having X-
linked recessive diseases do not suffer any effects or
complications since they have, on the average, 50% of
the gene product produced by the normal allele on theactive X-chromosome. However, only under rare excep-
tional conditions resulting in targeted inactivation of
the normal X-chromosome in most cells will a female
carrier of an X-linked recessive disease suffer from the
disease. A similar situation might be encountered in
female patients having the Turner’s syndrome with a
single X-chromosome. If they inherit mutant genes
linked to their only X-chromosome they suffer from
the pathogenetic phenotype(s) caused by these genes.
Contrary to the situation in females, males carrying mutant
genes on their single X-chromosome are affected with the dis-
ease since they do not have any reserve gene to replace for or
counteract the pathogenetic defects due to lack of another X-
chromosome.
8.2.3.1. X-linked recessive inheritance
These facts impart special inheritance features to X-linked
recessive disorders. In statistical terms, carrier mothers trans-
mit their defective gene to half of their male offspring who will
be affected, and transmit the normal gene to the other half who
will be normal. Female offspring who might inherit the mutant
gene will be carriers like their mothers and, usually, would not
show any disease manifestations as they concurrently inherit a
normal copy of the gene through the paternal X-chromosome
they inherit from their father.
As referred to previously, females might be affected with X-
linked recessive diseases under exceptional circumstances, for
instance in 45,X Turner syndrome if the only X-chromosome
they have carries the mutant gene, in abnormal Lyonization
states if inactivation targets exclusively the normal X-chromo-
some, via an affected father in addition to a carrier or affected
mother or, quite rarely, if they suffer a fresh mutation of their
normal allele in addition to the inherited mutant allele they al-
ready have.
8.2.3.2. X-linked dominant inheritance
X-Linked dominant genes, like autosomal dominant genes can
induce a disease phenotype when present in a single copy. So,
females carrying an X-linked dominant gene will show the dis-
ease similar to males carrying the same gene, albeit in a milder
form since they have another normal copy of the gene on the
other normal X-chromosome. They will also transmit this gene
to half of their male offspring thus having a 50% chance of
getting a normal male child and 50% chance of having an af-
fected male child.
Similarly, half of her female offspring who inherit the mu-
tant gene will be affected, sometimes in a milder form, and the
other half will be quite normal females.
Their affected male children, on the other hand, upon mat-
ing will transmit their affected X-linked dominant gene only to
all their daughters who will be affected, while none of their
male offspring who inherit the Y- chromosome from their
fathers will be affected [4].
8.2.4. Y-linked inheritance
Y-linked inheritance, or Holandric inheritance, refers to inher-
itance of traits or diseases caused by genes carried on the Y-
chromosome. Though the prime role of the Y-chromosome re-
sides in sex determination due to the effect of the SRY (sex-
Table 4 Genes located on the Y-chromosome (Y-linked genes).
SRY: Sex-determining region RBM2: RNA binding motif protein 2
TDF: Testis determining factor RBM1: RNA binding motif protein, Y-chromosome, family 1, member A1
TSPY: Testis-speciﬁc protein CSF2RY: Alpha subunit of granulocyte–macrophage colony-stimulating factor receptor
AZF1: Azoospermia factor 1 ANT3Y: Adenine nucleotide translocator-3
AZF2: Azoospermia factor 2 IL3RAY: Interleukin-3 receptor
DAZ: Deleted in azoospermia ASMTY: Acetyl-serotonin methyltransferase
AMELY/AMELX: Amelogenin RBM2: RNA binding motif protein 2
RPS4Y1/RPS4Y2/RPS4X: Ribosomal protein S4 UTY: Ubiquitously transcribed TPR gene on Y-chromosome
USP9Y: Ubiquitin speciﬁc peptidase 9, Y-linked PRKY: Protein kinase, Y-linked
BPY2: Testis-speciﬁc basic protein Y 2 ZFY: Zinc ﬁnger protein
Table 5 Pseudoautosomal region genes.
ASMT: N-Acetyl-serotonin
O-methyltransferase
CSF2RA: Granulocyte
macrophage colony-
stimulating factor receptor
IL3RA: Interleukin-3 receptor,
alpha (low aﬃnity) (CD 123)
ASMTL: N-Acetyl-serotonin
O-methyltransferase-like protein
SFRS17A: Splicing factor,
arginine/serine-rich 17A
P2RY8: P2Y purinoceptor 8
CD99: CD99 antigen (cluster of
diﬀerentiation 99)
DHRSXY: Dehydrogenase/
reductase (SDR family)
X-linked
PLCXD1: Phosphatidylinositol-
speciﬁc phospholipase C, X domain
containing 1
CRLF2: Cytokine receptor-like
factor 2
GTPBP6:GTP binding protein
6
PPP2R3B: Serine/threonine–
protein phosphatase 2A regulatory
subunit beta
SHOX: Short stature homeobox
gene
SLC25A6: ADP/ATP
translocase 3 (solute carrier
family 25 member 6)
XG: XG antigen
ZBED1: Zinc ﬁnger BED
domain-containing protein 1
SPRY3: Protein sprouty
homolog 3
SYBL1: Vesicle-associated
membrane protein 7 (VAMP-7)
IL9R: Interleukin 9 receptor
(IL9R) (CD129 or cluster of
diﬀerentiation 129)
PCDH11X: Protocadherin 11
X-linked
PCDH11Y: Protocadherin 11
Y-linked
CXYorf1: WAS protein family
homolog 6 pseudogene
TGIF2LX: TGFB-induced
factor homeobox 2-like,
X-linked
TGIF2LY: TGFB-induced factor
homeobox 2-like, Y-linked
216 M.S.Z. Salemdetermining region) located on its long arm in driving the des-
tination of the primitive gonad toward differentiation into tes-
tes and maleness of the developing embryo, large numbers of
Y-linked genes have been deﬁned which have important func-
tions in the regulation of gene expression, of many metabolic
pathways as well as the regulation of immune functions (Ta-
ble 4). Certain Y-linked genes probably exert critical effects
on brain functions during development through deﬁning male
speciﬁc brain phenotypes, and hence male-typical behaviors.
An alternative perspective is that, in some cases, Y-linked
genes may act to attenuate sex differences, e.g. where the Y
homolog of an X-linked escaping inactivation performs a func-
tionally equivalent role [4].
8.2.5. Pseudoautosomal region of the X- and Y-chromosomes
The pseudoautosomal regions (PAR) are short regions of se-
quence homology shared between the X- and Y-chromosomes,
that pair and recombine during meiosis. Two of these regions
(PAR1 and PAR2) have been located at both ends of these
chromosomes. PAR1 is located at the terminal region of the
short arms and PAR2 at the tips of the long arms. Currently,
24 genes have been assigned to the PAR1 region and 4 geneshave been deﬁned in the PAR2 region (Table 5). The main
function of these pseudoautosomal regions is to allow proper
pairing and segregation of both chromosomes during meiosis
in males. Of relevant importance in this regard is the ﬁnding
that deletion of the PAR1 region of the Y-chromosome results
in failure of X-Y pairing and male sterility. Also, haploinsufﬁ-
ciency of the SHOX gene (short stature homeobox-contain-
ing), located in PAR1 contributes to certain features in
Turner syndrome. Both chromosomes, however, share other
regions of sequence homology along their lengths.
Genes of the pseudoautosomal regions (PAR1 and PAR2)
behave like autosomal genes and recombine during meiosis.
Normal males have two copies of these genes: one in the
pseudoautosomal region of their Y-chromosome, the other
in the corresponding pseudoautosomal portion of their X-
chromosome. Normal females also have two copies of each
of the pseudoautosomal genes, as each of their two X-chromo-
somes contains a pseudoautosomal region. During meiosis,
crossing over between the X- and Y-chromosomes is restricted
only to the pseudoautosomal regions, thus, PAR genes exhibit
an autosomal, rather than sex-linked, pattern of inheritance.
So, females can inherit an allele originally present on the
pseudoautosomal region of the Y-chromosome of their father
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pseudoautosomal region of the X-chromosome of their father.
Since all pseudoautosomal genes escape X-inactivation they
are candidates for having gene dosage effects in sex chromo-
some aneuploidy conditions like the Turner syndrome, Kline-
felter syndrome, triple X syndrome and the like [5].
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